The report, not made public, was commissioned by the main US pharmaceutical lobby, the Pharmaceutical Research and ...

The United States has a $115.5 billion trade deficit in pharmaceutical products, which the Trump administration has suggested ...

A new analysis by Charles River Associates, commissioned by European industry group EFPIA, suggests that a proposed reward ...

Trump’s planned pharmaceutical tariffs would raise costs by $51bn annually, report finds - Prices of medication and other ...

In the ensuing years, the pharma supply chain will become even more complex, requiring increasingly agile and responsive logistics to support the development of personalized medicine. Sustainability ...

Aspen’s share price plummeted by 30% after it warned shareholders that its earnings could significantly decline due to a ...

The European Commission has no plans to withdraw or revise its proposed overhaul of EU pharmaceutical rules, despite mounting ...

Pharmaceutical Technology® Group spoke with Erik Wiklund, CEO of Circio, about the future of M&A in the bio/pharmaceutical industry and the struggle small biotech companies face raising funds.

As the pharmaceutical industry continues to evolve with increasing regulatory expectations, this success story provides ...

Pharmaceuticals are currently exempt from a baseline 10 per cent tax Mr Trump has placed on goods entering the US, but the US ...

The Minister of Trade, Agribusiness, and Industry, Elizabeth Ofosu-Adjare, has announced the government’s plan to launch a ...